Yüklüyor......
Integrating Novel Therapeutic Monoclonal Antibodies into the Management of Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is an immunosuppressive malignancy. Interest in developing novel immunotherapies in HNSCC has been reawakened by the success of cetuximab, a therapeutic monoclonal antibody (mAb) against the epidermal growth factor receptor which likely relies on immune...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4095869/ https://ncbi.nlm.nih.gov/pubmed/24222079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28380 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|